Anifrolumab [CAS 1326232-46-5]
Partner: MedChemexpress LLC
| CAS No: | 1326232-46-5 |
| Applications: | COVID-19-immunoregulation |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Anifrolumab] |
| Purity: | 99.48 |
| Description: | Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research[1][2]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
